Controversies in Screening and Diagnosis of Gestational Diabetes: Cuba’s Position
Fuente:
Redalyc
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artículo científico |
| Lingua: | en |
| Pubblicazione: |
Medical Education Cooperation with Cuba
2016
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1876473177157140480 |
|---|---|
| author | Pilar Hernández-García |
| author_facet | Pilar Hernández-García |
| contents | Controversies in Screening and Diagnosis of Gestational Diabetes: Cuba’s Position Pilar Hernández-García Jacinto Lang-Prieto Marelys Yanes-Quesada Ileydis Iglesias-Marichal Antonio Márquez-Guillén Jeddú Cruz-Hernández Medicina Cuba screening diagnosis early detection early diagnosis Gestational diabetes is the most common endocrine disorder aႇ ecting pregnant women and its prevalence is on the rise. Prevalence in Cuba is about 5.8%, and global prevalence ranges from 2% to 18% depending on the criteria applied. Gestational diabetes can lead to adverse gestational outcomes, such as fetal death, preterm delivery, dystocia, perinatal asphyxia and neonatal complications. Prompt, accurate diagnosis allowing early treatment can bene¿ t both mother and child. The disease is asymptomatic, so clinical laboratory testing plays a key role in its screening and diagnosis. Cuba’s approach to diabetes screening and diagnosis diႇ ers from some international practices. All pregnant women in Cuba are screened with a fasting plasma glucose test and diagnosed using modi¿ ed WHO criteria. Some international recommendations are to skip the screening step and instead follow the diagnostic criteria of the Hyperglycemia and Adverse Pregnancy Outcomes study. In Cuba, gestational outcomes for women with diabetes (including gestational diabetes) are satisfactory (preeclampsia 5%; preterm delivery 12%; neonatal macrosomia 7.5%; congenital abnormalities 4.3% and perinatal deaths 4.8%). These data do not indicate a need to change established screening and diagnostic criteria. 2016 artículo científico 1555-7960 https://www.redalyc.org/articulo.oa?id=437546762010 en http://www.redalyc.org/revista.oa?id=4375 MEDICC Review application/pdf Medical Education Cooperation with Cuba MEDICC Review (Estados Unidos de América) Num.3 Vol.18 |
| format | Artículo científico |
| id | redalyc_437546762010 |
| institution | Redalyc |
| language | en |
| publishDate | 2016 |
| publisher | Medical Education Cooperation with Cuba |
| spellingShingle | Controversies in Screening and Diagnosis of Gestational Diabetes: Cuba’s Position Pilar Hernández-García Medicina Cuba screening diagnosis early detection early diagnosis Controversies in Screening and Diagnosis of Gestational Diabetes: Cuba’s Position Pilar Hernández-García Jacinto Lang-Prieto Marelys Yanes-Quesada Ileydis Iglesias-Marichal Antonio Márquez-Guillén Jeddú Cruz-Hernández Medicina Cuba screening diagnosis early detection early diagnosis Gestational diabetes is the most common endocrine disorder aႇ ecting pregnant women and its prevalence is on the rise. Prevalence in Cuba is about 5.8%, and global prevalence ranges from 2% to 18% depending on the criteria applied. Gestational diabetes can lead to adverse gestational outcomes, such as fetal death, preterm delivery, dystocia, perinatal asphyxia and neonatal complications. Prompt, accurate diagnosis allowing early treatment can bene¿ t both mother and child. The disease is asymptomatic, so clinical laboratory testing plays a key role in its screening and diagnosis. Cuba’s approach to diabetes screening and diagnosis diႇ ers from some international practices. All pregnant women in Cuba are screened with a fasting plasma glucose test and diagnosed using modi¿ ed WHO criteria. Some international recommendations are to skip the screening step and instead follow the diagnostic criteria of the Hyperglycemia and Adverse Pregnancy Outcomes study. In Cuba, gestational outcomes for women with diabetes (including gestational diabetes) are satisfactory (preeclampsia 5%; preterm delivery 12%; neonatal macrosomia 7.5%; congenital abnormalities 4.3% and perinatal deaths 4.8%). These data do not indicate a need to change established screening and diagnostic criteria. 2016 artículo científico 1555-7960 https://www.redalyc.org/articulo.oa?id=437546762010 en http://www.redalyc.org/revista.oa?id=4375 MEDICC Review application/pdf Medical Education Cooperation with Cuba MEDICC Review (Estados Unidos de América) Num.3 Vol.18 |
| title | Controversies in Screening and Diagnosis of Gestational Diabetes: Cuba’s Position |
| topic | Medicina Cuba screening diagnosis early detection early diagnosis |
| url | https://www.redalyc.org/articulo.oa?id=437546762010 |